Tag: Jim Shannon

The below Parliamentary question was asked by Jim Shannon on 2015-10-27.

To ask the Secretary of State for Health, what steps the NHS takes to identify symptoms of dementia among elderly patients in hospital.

Jane Ellison

NHS England developed the Commissioning for Quality and Innovation (CQUIN) framework for 2015/16 which contains a national goal on improving dementia care. The dementia CQUIN aims to help identify patients with dementia and other causes of cognitive impairment, alongside their other medical conditions and to prompt appropriate referral and follow up after they leave hospital.

The three main aims of the CQUIN are to identify, assess and refer those presenting with symptoms of dementia. In order to identify individuals with dementia members of staff will ask members of the family or friends of a person admitted to hospital if the patient has suffered any problems with their memory in the last 12 months. If there is evidence to suggest a problem with their memory, that person will be given a dementia risk assessment and then based on the results of the assessment a referral would be made for further support either to a liaison team, a memory clinic or a general practitioner.

The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges on the prevention of still births.

Ben Gummer

Since May 2015, Ministers at the Department have not held any meetings with the Royal Colleges to specifically discuss the prevention of stillbirths. However, the Department has been working in partnership with Sands (the Stillbirth and Neonatal Death charity) and a range of key organisations, including NHS England, Public Health England, the Royal College of Midwives and the Royal College of Obstetricians and Gynaecologists, to drive forward a stillbirth prevention work programme.

The below Parliamentary question was asked by Jim Shannon on 2015-10-20.

To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges on the use of cancer drugs to slow down Parkinson’s disease.

Jane Ellison

My Rt. hon. Friend the Secretary of State meets regularly with the Royal Colleges, however he has not specifically discussed this matter. The National Institute for Health and Care Excellence is currently updating its guidance on Parkinson’s disease to take into account the latest evidence.

The below Parliamentary question was asked by Jim Shannon on 2015-10-27.

To ask the Secretary of State for Health, what recent discussions he has had with (a) pharmaceutical companies and (b) the Royal Colleges on making colchicine available on the NHS for the treatment of cancer.

George Freeman

No such discussions have taken place. We understand that a potential treatment for cancer derived from colchicine is currently in development and clinical trials are due to start in 2016.

The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

To ask the Secretary of State for Health, by when he plans for new drug treatments for sepsis and Acute Respiratory Disease Syndrome to be available on the NHS.

George Freeman

The National Institute for Health and Care Excellence (NICE) is currently developing a clinical guideline on the recognition, diagnosis and management of severe sepsis. The guideline will consider the full range of treatment options for sepsis. NICE currently plans to publish this guidance in July 2016.

There are no plans for NICE to develop technology appraisal guidance on the use of new drug treatments for sepsis or acute respiratory distress syndrome (ARDS).

NHS England has advised that there have been many trials of new treatments for ARDS but no consistent benefit has been found in any of these.

In the absence of NICE guidance, funding decisions for individual treatments should be made by the relevant National Health Service commissioner, based on an assessment of the available evidence. Commissioners are also required to have processes in place for the consideration of exceptional funding requests.

The below Parliamentary question was asked by Jim Shannon on 2015-10-27.

To ask the Secretary of State for Health, how many people have received atrial fibrillation in the last five years.

Jane Ellison

This information is not collected centrally.

The below Parliamentary question was asked by Jim Shannon on 2015-10-27.

To ask the Secretary of State for Health, how many people have been diagnosed with Castleman disease in each of the last five years.

George Freeman

Information on the number of diagnoses of Castleman disease is not held centrally.

The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

To ask the Secretary of State for Business, Innovation and Skills, what recent steps he has taken to prevent pub closures.

Anna Soubry

This Government is committed to supporting a fair and flourishing pubs sector. We have scrapped the beer duty escalator, and at Budget 2015 we cut beer duty for the third year in a row. Through the Community Right to Bid, we are giving communities in England a fairer chance to bid to buy and run their pub by listing it as an Asset of Community Value. We are introducing a statutory Pubs Code and an independent Adjudicator to govern the relationship between large pub-owning companies and the thousands of tenants that run tied pubs across England and Wales. These measures will help to ensure the pubs industry continues to thrive, to the benefit of all those who work hard to make the pub the mainstay of our communities.

The below Parliamentary question was asked by Jim Shannon on 2015-10-19.

To ask the Secretary of State for Health, if he will make available on the NHS cyber-knife technology to treat cancer and reduce time spent in hospital by cancer patients.

Jane Ellison

Cyber-knife technology is one of three treatment platforms that can be used to treat a number of cancers, together with some benign conditions. The treatment platforms deliver stereotactic radiotherapy, both to the body (stereotactic ablative body radiotherapy) which is commissioned for the treatment of non-small cell lung cancer, and to the head (stereotactic radiosurgery/radiotherapy) for a range of cancer indications covered by clinical commissioning policies which can be found at:

www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d05/

It should be noted that NHS England commissions on the basis of clinical indication and not specifically for treatment platforms. The choice of treatment platform used is ultimately a decision made by trusts themselves.

“

The below Parliamentary question was asked by Jim Shannon on 2015-10-27.

To ask the Secretary of State for Health, how many people have been diagnosed with Lyme disease in each of the last five years.

Jane Ellison

The total number of laboratory confirmed Lyme disease cases for each of the last five years is shown in Table 1.

Table 1: Total number of laboratory confirmed Lyme disease cases for each of the last five years:

Year	Total number of Lyme disease cases laboratory confirmed
2010	905
2011	959
2012	1,040
2013	878
2014	735